E-GMS

• This major step will enable sales and distribution of the new product in the European Union (EU).
• “We are pleased that Volta’s AF-Xplorer™ is now available in the EU to assist electrophysiologists in the treatment of patients with atrial fibrillation,” said Theophile Mohr-Durdez, Volta Medical CEO and co-founder.
• This methodology facilitates a standardized approach to pinpointing what is known as spatiotemporal dispersed EGMs, a suspected source of AF.
• Volta’s AF-Xplorer™ also received U.S. Food and Drug Administration (FDA) clearance in January 2023 for the real-time manual or automatic annotation of spatiotemporal dispersions during AF and atrial tachycardia (AT) procedures.

• Celltrion Group announced that the merger agreement between Celltrion, Inc. (KRX:068270) (“Celltrion”) and Celltrion Healthcare Co., Ltd. (KOSDAQ:091990) (“Celltrion Healthcare”) was approved at the extraordinary general meeting of shareholders (“EGM”) of the two companies held at Songdo Convensia and Sheraton Grand Incheon Hotel, respectively, on October 23, 2023.
• Under the merger plan, Celltrion will merge Celltrion Healthcare and issue Celltrion shares to Celltrion Healthcare shareholders.
• Celltrion Healthcare shareholders will receive 0.4492620 shares of Celltrion for each Celltrion Healthcare share they own.
• The merger price per share is KRW 148,853 for Celltrion and KRW 66,874 for Celltrion Healthcare.

• Similar features are now being used to transform online sports betting, significantly increasing the risk of problem gambling.
• Sports betting is one the UK’s most popular forms of gambling.
• Although not quite as fast as EGMs, the increased speed at which in-play sports bets can now be placed is linked to problem gambling.
• Using the cash-out feature is also associated with problem gambling.

Sports betting in the near future

• Our recent research identified three patents that aim to add augmented reality (AR) to the sports betting experience.
• AR typically uses goggles or mobile phones to overlap computer-generated imagery onto a player’s view of the real world.
• Research shows immersion is pivotal in fuelling problematic gambling behaviour and disengaging from an AR sports betting session could be very challenging.
• However, introducing such competition in online sports betting might exacerbate “tilting” – when a person makes poor betting decisions in response to loss or pressure.

Regulation and policy

• Gambling regulation is notorious for its lack of foresight.
• So while more forward-looking regulation and policy is needed to protect consumers from the harmful evolution of sports betting, the uncertainty and complexity surrounding new sports betting technologies only adds to the challenge of regulating this industry.
• Thanks to new technology such as AI and AR, this industry is already evolving at a faster pace than regulation can keep up with.
• Philip Newall has received travel and accommodation funding from Alberta Gambling Research Institute, and received open access fee funding from Gambling Research Exchange Ontario.

• These innovations help streamline workflows, improve patient outcomes and offer tighter support for the industry’s top electronic health record (EHR) systems.
• More than 300 hospitals nationwide trust Glytec’s eGlycemic Management System® (eGMS®) to ensure safe and effective glycemic management for their patients.
• “Glytec is leading the way to a future where every hospital across the country provides the highest quality glycemic care possible,” said Jordan Messler, MD, Chief Medical Officer at Glytec.
• For a demo of Glucommander at ADCES23, visit the Glytec booth (#1915), or contact Glytec to schedule in advance at https://glytecsystems.com/contact-us/ .